Dr. Ziad Al-Ali
👤 SpeakerAppearances Over Time
Podcast Appearances
The study looked at data on more than 600,000 people with type 2 diabetes.
All were in the VA health system.
Dr. Ziad Al-Ali of Washington University in St.
Louis says those treated with GLP-1 drugs like Ozempic were less likely to be diagnosed with substance use disorder.
They had less risk across several addictive substances, including opioids, cocaine, nicotine, alcohol, cannabis, and other substances.
For most of these substances, the risk was about 15 to 20 percent lower.
The study also found that people with a history of addiction were less likely to overdose or require emergency treatment.
Alali says the results are promising but need to be confirmed in controlled trials.
The study looked at data on more than 600,000 people with type 2 diabetes.
All were in the VA health system.
Dr. Ziad Al-Ali of Washington University in St.
Louis says those treated with GLP-1 drugs like Ozempic were less likely to be diagnosed with substance use disorder.
They had less risk across several addictive substances, including opioids, cocaine, nicotine, alcohol, cannabis, and other substances.
For most of these substances, the risk was about 15 to 20 percent lower.
The study also found that people with a history of addiction were less likely to overdose or require emergency treatment.
Alali says the results are promising but need to be confirmed in controlled trials.
The study looked at data on more than 600,000 people with type 2 diabetes.
All were in the VA health system.